Organon & Co.
Price
Key statistics
- Forward rate
- $0.08
- Yield
- 0.58%
- Payout ratio
- 10.26%
- Frequency
- Quarterly
- 2026-08-14$0.02
Organon & Co. is a global pharmaceutical company focused on women’s health, biosimilars, and established prescription medicines. Organon & Co. develops and delivers health solutions across a broad portfolio that includes therapies and medical devices used in reproductive health, contraception, fertility, dermatology, cardiovascular care, respiratory conditions, and other areas of general medicine. The company serves patients and healthcare providers in more than 140 markets through wholesalers, retailers, hospitals, government agencies, and managed care organizations. Its women’s health business is a central part of the portfolio, supported by biosimilars and well-known legacy brands that address everyday treatment needs across multiple therapeutic areas. Organon & Co. operates as a diversified healthcare provider with a strong international footprint and a product mix designed to meet ongoing demand for prescription treatments and essential medicines.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Kevin Ali
- Employees
- 10,000
- Headquarters
- Jersey City, NJ, United States
- Website
- www.organon.com